71 filings
6-K
MOLN
Molecular Partners Ag
14 Jun 24
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
10:44am
6-K
MOLN
Molecular Partners Ag
11 Jun 24
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
10:16am
6-K
MOLN
Molecular Partners Ag
3 Jun 24
Current report (foreign)
5:06pm
6-K/A
MOLN
Molecular Partners Ag
17 May 24
Current report (foreign) (amended)
6:25am
6-K
MOLN
Molecular Partners Ag
16 May 24
Current report (foreign)
4:00pm
6-K
bkog5
26 Mar 24
Molecular Partners Publishes Invitation to Annual General Meeting 2024
9:34am
6-K
e6cv42j0 33x8
8 Jan 24
Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
12:33pm
6-K
875yt
5 Jan 24
Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
4:00pm
6-K
h13qwx2rx8rv8t
11 Dec 23
Current report (foreign)
6:05am
6-K
aabc8u0h1i6
2 Nov 23
Current report (foreign)
6:01am
6-K
3jrn0cc04 vj
26 Oct 23
Current report (foreign)
4:00pm
6-K
5sh7q5y1bv4hq ue
24 Aug 23
Molecular Partners Reports H1 2023 Corporate Highlights and Financials
4:02pm
S-8
kelf7
28 Jun 23
Registration of securities for employees
8:34am
6-K
5o2rh hxgtpp08
12 May 23
Current report (foreign)
6:05am
6-K
062m59yz
11 May 23
Current report (foreign)
4:00pm
6-K
rgy5wto
13 Mar 23
Molecular Partners Publishes Invitation to Annual General Meeting 2023
9:30am
6-K
c3dmjipz g2iwgfagz
9 Mar 23
Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022
4:00pm
6-K
wdb5lsoa7
17 Jan 23
Current report (foreign)
7:00am